INNOCAN PHARMA CORPORATION

No trades
See on Supercharts
Market capitalization
‪88.44 M‬CAD
−0.025CAD
‪−4.90 M‬CAD
‪3.33 M‬CAD
‪208.22 M‬
Beta (1Y)
−0.12

About INNOCAN PHARMA CORPORATION

CEO
Iris Or Gabi Bincovich
Headquarters
Herzliya
Founded
2018
ISIN
CA45783P1027
FIGI
BBG00PBK8GX7
InnoCan Pharma Corp. operates as a pharmaceutical tech company. The firm focuses on the development of several drug delivery platforms combining cannabidiol (“CBD”) with other pharmaceutical ingredients as well as the development and sale of CBD-integrated pharmaceuticals. It operates through the following segments: the research and development of CBD loaded exosomes (“CLX”), the research and development of the use of CBD loaded liposomes and the commercialization and sale of branded CBD integrated pharmaceutical and topical treatment products. The company was founded in October2017 and is headquartered in Herzliya, Israel.
Performance
Revenue to profit conversion
Debt level and coverage
Earnings
Next:
‪0.00‬
Summarizing what the indicators are suggesting.
Oscillators
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Oscillators
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Summary
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Summary
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Summary
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Moving Averages
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Moving Averages
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Trade directly on the supercharts through our supported, fully-verified and user-reviewed brokers.
Interactive Brokers
Stocks, Forex, Futures, Bonds
4.4Very Good

See all brokers